There	EX	_
are	VBP	_
conflicting	VBG	CUE-1
studies	NNS	CUE-1
,	,	_
and	CC	_
it	PRP	_
is	VBZ	_
unclear	JJ	CUE-2
if	IN	_
phytoestrogens	NNS	_
have	VBP	_
any	DT	_
effect	NN	_
on	IN	_
the	DT	_
cause	NN	_
or	CC	_
prevention	NN	_
of	IN	_
cancer	NN	_
in	IN	_
females	NNS	_
.	.	_

Epidemiological	JJ	_
studies	NNS	_
showed	VBD	_
a	DT	_
protective	JJ	_
effect	NN	_
against	IN	_
breast	NN	_
cancer	NN	_
.	.	_

'	``	_
In	IN	_
vitro	FW	_
'	''	_
studies	NNS	_
concluded	VBD	_
that	IN	_
females	NNS	_
with	IN	_
current	JJ	_
or	CC	_
past	JJ	_
breast	NN	_
cancer	NN	_
should	MD	_
be	VB	_
aware	JJ	_
of	IN	_
the	DT	_
risks	NNS	_
of	IN	_
potential	JJ	_
tumor	NN	_
growth	NN	_
when	WRB	_
taking	VBG	_
soy	NN	_
products	NNS	_
,	,	_
as	IN	_
they	PRP	_
can	MD	_
stimulate	VB	_
the	DT	_
growth	NN	_
of	IN	_
estrogen	NN	_
receptor	NN	_
-	HYPH	_
positive	JJ	_
cells	NNS	_
in	IN	_
vitro	NN	_
.	.	_

A	DT	_
2006	CD	_
review	NN	_
article	NN	_
stated	VBD	_
the	DT	_
opinion	NN	_
that	IN	_
not	RB	_
enough	JJ	_
information	NN	_
is	VBZ	_
available	JJ	_
,	,	_
and	CC	_
that	IN	_
even	RB	_
if	IN	_
isoflavones	NNS	_
have	VBP	_
mechanisms	NNS	_
to	TO	_
inhibit	VB	_
tumor	NN	_
growth	NN	_
,	,	_
'	''	_
in	IN	_
vitro	FW	_
'	''	_
results	NNS	_
justify	VBP	_
the	DT	_
need	NN	_
to	TO	_
evaluate	VB	_
,	,	_
at	IN	_
cellular	JJ	_
level	NN	_
,	,	_
the	DT	_
impact	NN	_
of	IN	_
isoflavones	NNS	_
on	IN	_
breast	NN	_
tissue	NN	_
in	IN	_
females	NNS	_
at	IN	_
high	JJ	_
risk	NN	_
for	IN	_
breast	NN	_
cancer	NN	_
.	.	_

The	DT	_
generally	RB	CUE-1
accepted	VBN	CUE-1
position	NN	_
on	IN	_
this	DT	_
topic	NN	_
is	VBZ	_
that	IN	_
phytoestrogens	NNS	_
may	MD	CUE-2
be	VB	_
beneficial	JJ	_
for	IN	_
healthy	JJ	_
females	NNS	_
and	CC	_
that	IN	_
females	NNS	_
with	IN	_
known	VBN	_
breast	NN	_
cancer	NN	_
should	MD	_
be	VB	_
aware	JJ	_
of	IN	_
potential	JJ	_
risks	NNS	_
and	CC	_
consider	VB	_
avoiding	VBG	_
consumption	NN	_
until	IN	_
more	JJR	_
information	NN	_
is	VBZ	_
available	JJ	_
.	.	_

